X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15352) 15352
Publication (1471) 1471
Newspaper Article (682) 682
Book Review (344) 344
Book Chapter (217) 217
Newsletter (155) 155
Book / eBook (94) 94
Magazine Article (61) 61
Transcript (50) 50
Dissertation (36) 36
Trade Publication Article (31) 31
Conference Proceeding (19) 19
Report (13) 13
Government Document (11) 11
Reference (7) 7
Web Resource (5) 5
Data Set (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8644) 8644
parkinson's disease (7809) 7809
index medicus (7641) 7641
male (5411) 5411
animals (5338) 5338
neurosciences (5311) 5311
parkinsons-disease (4810) 4810
female (4049) 4049
clinical neurology (3589) 3589
middle aged (2774) 2774
aged (2762) 2762
parkinsons disease (2686) 2686
neurology (2660) 2660
dopamine (2372) 2372
parkinson disease - drug therapy (2264) 2264
rats (2158) 2158
neurodegenerative diseases (1996) 1996
movement disorders (1855) 1855
neurons (1768) 1768
parkinson’s disease (1741) 1741
analysis (1692) 1692
mice (1682) 1682
brain (1608) 1608
pharmacology & pharmacy (1601) 1601
oxidative stress (1569) 1569
adult (1564) 1564
disease models, animal (1503) 1503
parkinson disease, secondary - chemically induced (1436) 1436
neurodegeneration (1376) 1376
alzheimers-disease (1322) 1322
research (1289) 1289
psychiatry (1211) 1211
care and treatment (1185) 1185
parkinson disease - physiopathology (1144) 1144
nervous system diseases (1131) 1131
nervous system (1119) 1119
dopamine - metabolism (1100) 1100
neuroprotection (1098) 1098
biochemistry & molecular biology (1059) 1059
antiparkinson agents - therapeutic use (1009) 1009
rats, sprague-dawley (1002) 1002
levodopa (1000) 1000
cell biology (984) 984
parkinson disease - complications (982) 982
dementia (981) 981
substantia-nigra (963) 963
alzheimer's disease (962) 962
basal ganglia (958) 958
article (957) 957
medical research (947) 947
apoptosis (939) 939
parkinson disease (937) 937
proteins (934) 934
alpha-synuclein (932) 932
treatment outcome (923) 923
health aspects (910) 910
levodopa - therapeutic use (905) 905
disease (874) 874
medicine (856) 856
aged, 80 and over (848) 848
parkinson disease - metabolism (836) 836
parkinson disease, secondary - drug therapy (833) 833
risk factors (813) 813
neurons - metabolism (802) 802
rodents (802) 802
parkinson disease - therapy (784) 784
double-blind (781) 781
neurons - drug effects (777) 777
drug therapy (767) 767
studies (758) 758
neuroprotective agents - pharmacology (744) 744
mice, inbred c57bl (741) 741
medicine, experimental (729) 729
physiological aspects (710) 710
parkinson disease - pathology (705) 705
dose-response relationship, drug (703) 703
clinical trials (701) 701
diagnosis (698) 698
inflammation (693) 693
medicine & public health (689) 689
patients (680) 680
research article (680) 680
biomedicine (656) 656
time factors (635) 635
quality of life (634) 634
dopaminergic-neurons (628) 628
mptp (626) 626
tyrosine 3-monooxygenase - metabolism (624) 624
dopamine receptors (616) 616
cells, cultured (610) 610
multidisciplinary sciences (594) 594
substantia nigra (583) 583
medicine, research & experimental (578) 578
neurotoxicity (577) 577
surgery (569) 569
review (561) 561
alzheimers disease (556) 556
immunohistochemistry (555) 555
corpus striatum - metabolism (547) 547
development and progression (542) 542
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (62) 62
Online Resources - Online (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Providence Healthcare - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Baycrest Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Missing (1) 1
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Online (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Music - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16304) 16304
German (92) 92
French (64) 64
Spanish (53) 53
Russian (44) 44
Japanese (22) 22
Italian (16) 16
Portuguese (13) 13
Chinese (10) 10
Polish (10) 10
Dutch (8) 8
Swedish (5) 5
Romanian (4) 4
Czech (3) 3
Danish (3) 3
Norwegian (2) 2
Turkish (2) 2
Arabic (1) 1
Finnish (1) 1
Hungarian (1) 1
Korean (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 02/2017, Volume 127, Issue 2, pp. 720 - 734
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3355 - 3370
Axonal degeneration is one of the earliest features of Parkinson's disease pathology, which is followed by neuronal death in the substantia nigra and other... 
axonal degeneration | Parkinson's disease | rho kinase | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | dopaminergic cell death | CONTROLLED-TRIAL | SIGNALING PATHWAYS | REGENERATION | SUBSTANTIA-NIGRA | NEUROSCIENCES | CLINICAL NEUROLOGY | CELL-DEATH | COENZYME Q | IN-VITRO | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP | NEURITE OUTGROWTH | DOUBLE-BLIND | Neuroprotective Agents - therapeutic use | Rats, Wistar | Dopaminergic Neurons - pathology | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Male | Corpus Striatum - metabolism | Nerve Degeneration - chemically induced | Neuroprotective Agents - metabolism | rho-Associated Kinases - antagonists & inhibitors | Parkinson Disease, Secondary - pathology | Neuroprotective Agents - pharmacology | Parkinson Disease, Secondary - drug therapy | Dopaminergic Neurons - physiology | Behavior, Animal - drug effects | Parkinson Disease, Secondary - chemically induced | Proto-Oncogene Proteins c-akt - metabolism | Cell Survival - physiology | Dopamine - metabolism | Disease Models, Animal | Substantia Nigra - enzymology | Cell Survival - drug effects | rho-Associated Kinases - physiology | Nerve Degeneration - enzymology | Mice, Inbred C57BL | Cells, Cultured | Axons - drug effects | Rats | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - therapeutic use | Behavior, Animal - physiology | MPTP Poisoning - drug therapy | MPTP Poisoning - enzymology | Parkinson Disease, Secondary - enzymology | Neurites - pathology | Dopaminergic Neurons - enzymology | Substantia Nigra - drug effects | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Axons - pathology | 1-Methyl-4-phenylpyridinium - toxicity | Mice | Nerve Degeneration - drug therapy | Proto-Oncogene Proteins c-akt - drug effects | Cell culture | Neuroprotection | Animal models | Cell survival | Dopamine | Neurodegenerative diseases | Substantia nigra | Central nervous system | AKT protein | Motor task performance | Rho-associated kinase | Axons | Regeneration | Metabolites | Neurodegeneration | Neostriatum | Axon guidance | Movement disorders
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 05/2011, Volume 286, Issue 18, pp. 16504 - 16515
Journal Article
Journal Article
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 07/2009, Volume 29, Issue 30, pp. 9651 - 9659
Journal Article
Journal Article
Journal Article
Journal Article